Why Centrus Energy Stock Crashed 26% in October
Centrus went shopping, and Wall Street isn't happy with its purchase.
In October, Centrus Energy's stock experienced a significant 26% decline, contrasting with the S&P 500's minor 0.5% drop. The downturn was driven by analysts' negative outlook and investor reactions to the company's acquisition of Westerman Holdings. The deal, valued at $95 million in cash and $21 million in equity, aims to enhance Centrus's adjusted earnings per share and bolster its supply chain resilience.
However, investors were skeptical, with Centrus shares falling over 4% on the acquisition announcement. Analyst opinions further soured, with Roth Capital cutting its price target for Centrus shares from $188 to $115 and expressing concerns about the company's Q3 financial results. Despite the short-term stock decline, Centrus remains a prominent player in the nuclear industry, specializing in producing high-assay low-enriched uranium (HALEU) for small modular reactors (SMRs).
The company's backlog of $5.4 billion in LEU and HALEU business suggests a promising future as the nuclear energy industry evolves.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
